Is Goodman Looking Beyond Japan?
Japanese distributor Goodman has recently made a couple of US acquisitions. And while the products will primarily feed Goodman's Japanese pipeline, some speculate that this Jappanese powerhouse in interventional cardiology is staking out a US presence.
You may also be interested in...
A decision by health technology assessment body NICE opens the door to broaden the use of adalimumab, etanercept and infliximab by using them to treat moderate as well as severe rheumatoid arthritis.
India’s Granules has grown through increased market penetration of its existing products as well as new product launches. The company is planning to invest in expanding its API capacity, finished dosages and a new multiple unit pellet facility.
EU Business Round-Up: Probi Signs Oriflame Deal, Holland & Barrett Heads To China, Enzymatica Launches On Amazon
The latest European health & wellness business news: Probi partners with Swedish beauty firm Oriflame for probiotic launch; retailer Holland & Barrett enters the Chinese market with Alibaba's Tmall; and Enzymatica sees ColdZyme growth potential on Amazon.